Grant: Alliance Grants
University of Ottawa
$25,000.00
Nanoplasmonic biosensing platform
EF 2022-23
Résumé
Biosensing devices designed for fast, real-time identification of biomarkers are nowadays essential for many healthcare, medical and pharmaceutical applications. In addition, modern applications in these fields constantly demand for the next generation of biosensors to be miniaturized, automated, and multiplexed (i.e, capable to quantify several species of interest at the same time). Indeed, the development of next-generation biosensing devices capable of tackling such demands poses an important multidisciplinary challenge waiting to be addressed. An important health problem that demands such a next-generation biosensing device is that which originates from heart failure (HF) conditions, a global public health problem affecting millions of people across the world. This project aims at developing a proof-of-principle demonstration of a multiplexed nanoplasmonic biosensing platform for HF biomarker detection. Plasmonic biosensors, a class of optical biosensing devices, feature characteristics such as a fast real-time response, high sensitivity, and chip-scale integration. We will investigate a sensing architecture which is capable of multiplexing several tens of channels in order to carry out automated and accurate immunoassay measurements that hold the potential to outperform conventional clinical-based techniques (e.g. ELISA) used in the detection of HF biomarkers. The requested Catalyst grant will enable a synergetic interdisciplinary research collaboration to be initiated between the groups of Prof. Berini (uOttawa) and Prof. De Leon (Tec de Monterrey). The researchers' combined expertise will enable a new research avenue offering solutions that involve advanced biosensing technologies applied to important needs in medical diagnosis and medical research, such as the detection of biomarkers related to HF.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
572244-2022
Name nom
Berini, Pierre P
Department département
Electrical Engineering and Computer Science , School of
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2022
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
513
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Electrical and electronic machinery and equipment (including computer hardware)
Area of application fr
Machinerie et équipement électriques et électroniques (y compris matériel informatique)
Research subject code
2505
Research subject group en
Electrical and electronic engineering
Research subject group fr
Génie électrique et électronique
Research subject en
Photon devices
Research subject fr
Dispositifs photoniques
Installment
inst:1
Partie
1
Nb partie
1
Application title
Nanoplasmonic biosensing platform
Application summary
Biosensing devices designed for fast, real-time identification of biomarkers are nowadays essential for many healthcare, medical and pharmaceutical applications. In addition, modern applications in these fields constantly demand for the next generation of biosensors to be miniaturized, automated, and multiplexed (i.e, capable to quantify several species of interest at the same time). Indeed, the development of next-generation biosensing devices capable of tackling such demands poses an important multidisciplinary challenge waiting to be addressed. An important health problem that demands such a next-generation biosensing device is that which originates from heart failure (HF) conditions, a global public health problem affecting millions of people across the world. This project aims at developing a proof-of-principle demonstration of a multiplexed nanoplasmonic biosensing platform for HF biomarker detection. Plasmonic biosensors, a class of optical biosensing devices, feature characteristics such as a fast real-time response, high sensitivity, and chip-scale integration. We will investigate a sensing architecture which is capable of multiplexing several tens of channels in order to carry out automated and accurate immunoassay measurements that hold the potential to outperform conventional clinical-based techniques (e.g. ELISA) used in the detection of HF biomarkers. The requested Catalyst grant will enable a synergetic interdisciplinary research collaboration to be initiated between the groups of Prof. Berini (uOttawa) and Prof. De Leon (Tec de Monterrey). The researchers' combined expertise will enable a new research avenue offering solutions that involve advanced biosensing technologies applied to important needs in medical diagnosis and medical research, such as the detection of biomarkers related to HF.